Ginkgo Bioworks Holdings, Inc. (DNA) Reports Q4 Loss, Misses Revenue Estimates
Portfolio Pulse from
Ginkgo Bioworks Holdings, Inc. (DNA) reported a Q4 loss of $1.82 per share, missing the Zacks Consensus Estimate of a $1.45 loss. This is an improvement from the $3.60 loss per share a year ago.
February 26, 2025 | 12:45 am
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Ginkgo Bioworks reported a Q4 loss of $1.82 per share, missing analyst expectations of a $1.45 loss. Despite the miss, the loss is an improvement from the previous year's $3.60 per share.
The reported loss per share was worse than expected, which is typically negative for stock prices. However, the improvement from the previous year's loss may mitigate some negative impact.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100